Cooper Steputis

Private Equity / Venture Capital·OrbiMed

Bio

Professional summary

Public profile data identifies Cooper Steputis as working in private equity and venture capital at OrbiMed. Before OrbiMed, he was an Investment Banking Analyst at Solomon Partners and previously held analyst roles at Global Platinum Securities and Capstone Partners. He has a B.A. in Neuroscience and Molecular, Cellular & Developmental Biology from the University of Colorado Boulder, and his undergraduate research included work on intestinal organoid-matrix interactions.

Background

Career, education, and skills

Career history

OrbiMedPrivate Equity / Venture CapitalPresent
Solomon PartnersInvestment Banking Analyst2023
Global Platinum SecuritiesEquities Analyst2021 – 2023
University of Colorado BioFrontiers InstituteResearch Assistant
Solomon PartnersSummer Analyst2022 – 2022
Capstone PartnersSummer Analyst2021 – 2021

Education

University of Colorado BoulderB.A. in Neuroscience and Molecular, Cellular & Developmental Biology2019-2023

Other partners at OrbiMed

12 more profiles

View firm →

Aditya Tolia

Private Equity Senior Analyst

OrbiMed

Private Equity Senior Analyst at OrbiMed with prior Investec and PwC banking experience.

Financial modelingHealthcare investingInvestment bankingM&APrivate equity

Alexis Megibow

Private Equity Associate

OrbiMed

Private Equity Associate at OrbiMed.

Healthcare investingPrivate equityVenture capital

Ankesh Bhansali

Managing Director

OrbiMed

OrbiMed Asia Managing Director focused on healthcare private equity.

Asia healthcareCapital marketsHealthcare deliveryHealthcare private equityM&APharmaceuticals

Arun Sadhanandham

Managing Director

OrbiMed

OrbiMed Asia Managing Director investing in healthcare private equity.

Asia healthcareHealthcare deliveryHealthcare private equityInvestment bankingMedical devicesPharmaceuticals

Brendan Weber, CFA

Principal

OrbiMed

Principal on OrbiMed's Credit & Royalty team focused on structured credit and royalty financings.

Healthcare creditMedical devicesPharmaceuticalsRoyalty-based financingStructured credit

Carl Gordon

Managing Partner

OrbiMed

OrbiMed Managing Partner leading private equity and biotech company formation.

BiotechnologyBoard governanceCompany formationHealthcare private equityInnovative therapeuticsLife sciences

Carl L. Gordon

Managing Partner

OrbiMed

Carl L. Gordon is a Managing Partner at OrbiMed and leads the firm's private equity team.

Life-sciences private equityTherapeuticsVenture investing

Carter Neild

Managing Partner

OrbiMed

OrbiMed Managing Partner focused on healthcare royalties and Asia private investments.

Asia private investmentsHealthcare private equityHealthcare royaltiesInvestment managementStructured healthcare finance

Clay Daniel DeMarcus

Principal

OrbiMed

Principal focused on medical technology and non-therapeutics venture investing.

Healthcare equity researchHealthcare investment bankingMedical technologyNon-therapeuticsVenture-stage investing

Daniel Ying

Executive Director

OrbiMed

OrbiMed Asia Executive Director focused on pharma and biotech investments.

Asia healthcareBiotechnologyChina healthcare marketHealthcare private equityPharmaceuticals

David Bonita

General Partner

OrbiMed

OrbiMed General Partner and physician-investor in healthcare and therapeutics.

BiotechnologyBoard governanceHealthcare investingMedical devicesOncologyTherapeutics

David Wang

Partner

OrbiMed

OrbiMed Asia Partner focused on Greater China healthcare investments.

BiotechnologyDiagnostic imagingGreater China healthcareHealthcare private equityMedical diagnosticsPersonalized medicine

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile